Pristine Surgical LLC

Pristine Surgical LLC specializes in innovative single-use endoscopy solutions, enhancing surgical procedures with advanced technology and high-quality imaging. Founded in 2013 and headquartered in Manchester, US, Pristine Surgical LLC develops single-use surgical instruments. The company has successfully raised funds through two deals, including a Series D round in March 2022 which brought in USD 15 mn led by Ceros Capital Markets, marking an important milestone in its funding history. CEO Bryan Lord leads the company, which focuses on transforming surgical practices.

Pristine Surgical specializes in the development and provision of innovative single-use endoscopy solutions, notably its flagship product, the Summit™ 4K single-use surgical arthroscope. This device aims to streamline surgical visualization by eliminating complications associated with traditional endoscopic systems, such as maintenance challenges and contamination risks. The Summit™ endoscope offers high-definition imaging and is designed for easy, sterile use, thereby enhancing operational efficiency in the operating room. Pristine’s clientele primarily includes hospitals, surgical centers, and orthopedic specialists, with a focus on markets in North America, Europe, and Asia, where there is an increasing demand for efficient and safe surgical instruments.

Additional offerings under development include a comprehensive portfolio of rigid and flexible endoscopes, targeting various applications in both arthroscopy and laparoscopy. Pristine Surgical operates on a subscription-based pricing model, which provides transparency and predictability in costs for healthcare providers utilizing their products. This approach allows clients, such as surgical hospitals and orthopedic clinics, to access the Summit™ arthroscope and other single-use devices without the burden of high upfront costs typically associated with purchasing and maintaining traditional equipment. Additionally, the company implements a Scopes as a Service™ framework, where customers can subscribe to receive products on an as-needed basis, thus facilitating seamless operational management.

This transaction structure encourages long-term partnerships with clients who benefit from automated inventory management and streamlined procurement processes. Pricing details for individual products or services are structured to align with the needs of their client base, ensuring accessibility and usability across various healthcare settings. In March 2022, Pristine Surgical LLC raised USD 15 mn in Series D funding led by new investor Ceros Capital Markets. The company will use the funding to support the commercialization of its platform developed for surgical and diagnostic endoscopic procedures.

Future growth plans involve designing and launching new products in the endoscopic field to meet rising demand. Target markets for expansion include Europe and Asia, with initiatives slated for the upcoming years.